Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
European Urology|June 20, 2003
Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centersAlexandre R Zlotta, Xenofon Giannakopoulos, Odd Maehlum, et al.
Current Problems in Diagnostic Radiology|April 16, 2018
Comprehensive Imaging and Surgical Review of Urinary Diversions: What the Radiologist Needs to KnowArvind K Shergill, David C Wang, Seng Thipphavong, et al.
European Urology Open Science|August 2, 2021
Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have NotOtto Hemminki, Nathan Perlis, Johan Bjorklund, et al.
Clinical Therapeutics|May 10, 2005
The role of luteinizing hormone-releasing hormone therapy in locally advanced prostate cancer and biochemical failure: considerations for optimal usePierre Teillac, Aldo V Bono, Jacques Irani, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 27, 2007
Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressivenessShahrokh F Shariat, Alexandre R Zlotta, Raheela Ashfaq, et al.
European Urology|July 9, 2013
Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence reviewNathan Perlis, Alexandre R Zlotta, Joseph Beyene, et al.
Urology|July 15, 2019
Lynch Syndrome in Urologic Malignancies - What Does the Urologist Need to Know?Hanan Goldberg, Christopher J D Wallis, Zachary Klaassen, et al.
Current Urology Reports|June 27, 2002
Comparison of laparoscopic radical prostatectomy techniquesRenaud Bollens, Thierry Roumeguere, Marc Vanden Bossche, et al.
Expert Review of Anticancer Therapy|November 30, 2010
Optimal timing of radical cystectomy in T1 high-grade bladder cancerPeter J Boström, Sultan Alkhateeb, Bas W G van Rhijn, et al.
The Journal of Urology|April 11, 2003
An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or lessAlexandre R Zlotta, Mesut Remzi, Peter B Snow, et al.
Pageof 17